Home / Data / Women's Health Trial Tracker Women's Health Trial Tracker Women's Health Trial Tracker organizes records from ClinicalTrials.gov API v2 into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 5,000
Last changed 08/26/2026
Update schedule 55 1 * * * UTC
Coverage 05/26/2000–08/25/2026 Record Record Date Vuga Group Change Status Recency Days Public Significance Score Progesterone Therapeutic Regimen Plus Statins in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia 10/26/2023 INTERVENTIONAL unchanged 1,035.85 0 Prospective RegIstration Of the peRformance of the IoTa ADNEX Model in Dutch gYnaecological Practice 10/27/2023 OBSERVATIONAL unchanged 1,034.85 0 99mTc-MY6349 SPECT/CT Imaging in Trop2-positive Triple-negative Breast Cancer 10/27/2023 INTERVENTIONAL unchanged 1,034.85 0 Phase II Single Arm Trial of Low Dose Capecitabine in Patients With Advanced Breast Cancer 10/30/2023 INTERVENTIONAL unchanged 1,031.85 0 Biennial CEM in Women With a Personal History of Breast Cancer 10/30/2023 INTERVENTIONAL unchanged 1,031.85 0 Inorganic Nitrate Supplementation in Chronic Hypertensive Pregnancies 10/30/2023 INTERVENTIONAL unchanged 1,031.85 0 REDucing Hot FLASHes in Women Using Endocrine Therapy. 10/30/2023 INTERVENTIONAL unchanged 1,031.85 0 Dalpiciclib Plus AI (Neoadjuvant Endocrine Therapy) Compared With Neoadjuvant Chemotherapy in Early Breast Cancer (EBC) 10/30/2023 INTERVENTIONAL unchanged 1,031.85 0 Phase 1 Study of RP-6306 With Carboplatin and Paclitaxel in TP53 Ovarian and Uterine Cancer 10/30/2023 INTERVENTIONAL unchanged 1,031.85 0 Developmental Impacts of Microplastics Exposure in Early Life 10/30/2023 OBSERVATIONAL unchanged 1,031.85 0 Screening for Preeclampsia in Norway With Aspirin Discontinuation at 24-28 Weeks 10/31/2023 INTERVENTIONAL unchanged 1,030.85 0 Oral Health and Adverse Pregnancy Complications 10/31/2023 INTERVENTIONAL unchanged 1,030.85 0 The Anabolic Effect of Testosterone on Pelvic Floor Muscles 11/01/2023 INTERVENTIONAL unchanged 1,029.85 0 Prevention of Frailty With Fisetin and Exercise in Breast Cancer Survivors 11/02/2023 INTERVENTIONAL unchanged 1,028.85 0 Pregnancy Surveillance Program of Patients Exposed to Epidiolex/Epidyolex During Pregnancy 11/02/2023 OBSERVATIONAL unchanged 1,028.85 0 Enhancing the Effectiveness of Home-delivery Based Produce Prescription Program Implementation Strategies 11/02/2023 INTERVENTIONAL unchanged 1,028.85 0 EXERT-BCH Exercise Regimen to Improve Muscle Mass After Treatment of Breast Cancer 11/03/2023 INTERVENTIONAL unchanged 1,027.85 0 Prospective Assessment of HPV Associated Anogenital Pathology in Female Patients and Female Partners of Patients With Confirmed HPV Associated Oropharyngeal Carcinoma, PAP-OP Study 11/03/2023 OBSERVATIONAL unchanged 1,027.85 0 Evaluation of the Efficacy, Safety and Tolerability of BZ371A in Women with Sexual Arousal Disorder 11/03/2023 INTERVENTIONAL unchanged 1,027.85 0 Strategies for Implementing a Postpartum Lifestyle Intervention in WIC Clinics 11/03/2023 INTERVENTIONAL unchanged 1,027.85 0 The Effects of Laughter Yoga and Mindfulness-Based Stress Reduction (MBSR) Practices Applied to Women With Breast Cancer 11/03/2023 INTERVENTIONAL unchanged 1,027.85 0 Integrated Mental Health Care for Pregnant Women With HIV in Kenya: The Tunawiri Study 11/03/2023 INTERVENTIONAL unchanged 1,027.85 0 Systems Oncology Approach to Optimize Ovarian Cancer Treatment 11/07/2023 OBSERVATIONAL unchanged 1,023.85 0 A Study of WX390 in Patients With Advanced Solid Tumors 11/07/2023 INTERVENTIONAL unchanged 1,023.85 0 Project Sueño: Sleep & Understanding Early Nutrition in Obesity 11/07/2023 INTERVENTIONAL unchanged 1,023.85 0 Shanghai Ovarian Cancer and Family Care Project 11/07/2023 OBSERVATIONAL unchanged 1,023.85 0 A Female-Specific CBT Group for Veteran Women With Alcohol Use Disorder in VA Primary Care Settings 11/07/2023 INTERVENTIONAL unchanged 1,023.85 0 SELF-CERV Pivotal Study: SELF-Collection for CERVical Cancer Screening 11/07/2023 INTERVENTIONAL unchanged 1,023.85 0 First Line Treatment With Olaparib in Combination With Bevacizumab in HRD Positive Patients 11/07/2023 INTERVENTIONAL unchanged 1,023.85 0 Phase I Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes for Advanced HER2-Negative Breast Cancer 11/08/2023 INTERVENTIONAL unchanged 1,022.85 0 Phase I Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes as Neoadjuvant Therapy for HER2-Negative Breast Cancer 11/08/2023 INTERVENTIONAL unchanged 1,022.85 0 Impact of Incomplete Endometrial Ablation 11/08/2023 OBSERVATIONAL unchanged 1,022.85 0 Nordic Randomized Trial on Laparoscopic Versus Vaginal Cerclage 11/08/2023 INTERVENTIONAL unchanged 1,022.85 0 Pharmacological Inhibition of Lactation After 16 to 20 Week Abortion 11/08/2023 INTERVENTIONAL unchanged 1,022.85 0 Tart Cherry and Omega-3's for Aromatase Inhibitor Musculoskeletal Symptoms 11/08/2023 INTERVENTIONAL unchanged 1,022.85 0 Angiogenic Factors in the Conservative Management of Gestational Hypertension 11/08/2023 INTERVENTIONAL unchanged 1,022.85 0 BAT1308 Combined with Platinum-Based Chemotherapy± Bevacizumab for PDL1-Positive (CPS ≥1) Cervical Cancer 11/09/2023 INTERVENTIONAL unchanged 1,021.85 0 Adenomyosis Patients With Infertility and Immunological Factors 11/09/2023 OBSERVATIONAL unchanged 1,021.85 0 Prolonged Overnight Fasting and/or Exercise on Fatigue and Other Patient Reported Outcomes in Women With Hormone Receptor Positive Advanced Breast Cancer 11/09/2023 INTERVENTIONAL unchanged 1,021.85 0 Androgens and NAFLD Longitudinal Cohort Study 11/09/2023 OBSERVATIONAL unchanged 1,021.85 0 Prodromes of Menstrual Staphylococcal Toxic Shock 11/09/2023 OBSERVATIONAL unchanged 1,021.85 0 Study of Venous Outflow From the Lower Limbs in Patients With Pelvic Varicosities 11/09/2023 OBSERVATIONAL unchanged 1,021.85 0 RCT Comparing Intravaginal Laser Therapy to Sham in Post-menopausal Women with Recurrent Urinary Tract Infections 11/09/2023 INTERVENTIONAL unchanged 1,021.85 0 A Study of WX390 Combined With Toripalimab in Patients With Advanced Gastric-type Endocervical Adenocarcinoma With STK11 Mutations 11/09/2023 INTERVENTIONAL unchanged 1,021.85 0 The Efficacy and Safety of Utidelone Plus Tirelizumab and Bevacizumab for Advanced or Metastatic Triple-negative Breast Cancer (UTILIZABLE) :Single-arm, Prospective, Open Clinical Study 11/09/2023 INTERVENTIONAL unchanged 1,021.85 0 Brain and Voice Signatures in Teachers 11/13/2023 INTERVENTIONAL unchanged 1,017.85 0 A Phase III, Active-Controlled Study of SHR-A1811 Versus Trastuzumab Emtansine (T-DM1) in HER2-Positive Primary Breast Cancer Participants With Residual Invasive Disease Following Neoadjuvant Therapy 11/13/2023 INTERVENTIONAL unchanged 1,017.85 0 PelviSense, an Innovative, Non-invasive, Biofeedback Device for the Treatment of Stress Urinary Incontinence in Women 11/13/2023 INTERVENTIONAL unchanged 1,017.85 0 A Study to Evaluate the Safety of Ozanimod Exposure During Pregnancy in Women With Ulcerative Colitis and Their Infants 11/13/2023 OBSERVATIONAL unchanged 1,017.85 0 Contraceptive Efficacy Study of Ovaprene 11/13/2023 INTERVENTIONAL unchanged 1,017.85 0
Source U.S. National Library of Medicine, ClinicalTrials.gov API v2 · official record · retrieved 08/26/2026 · upstream last modified 08/26/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. National Library of Medicine
Required notice Study records are informational and do not provide diagnosis, treatment advice, or an assessment of individual risk. What we add We compute Vuga Group, Change Status, Recency Days, Public Significance Score using the documented compute method. · methodology